The At1g33340 antibody is a polyclonal antibody raised against the protein encoded by the At1g33340 gene. This gene is annotated in the Arabidopsis genome but remains functionally uncharacterized in public databases. The antibody’s target protein is inferred to play a role in plant-specific processes, potentially linked to cellular signaling or metabolic pathways, though its exact biological function requires further study .
Host species: Typically produced in rabbits or other model organisms.
Clonality: Polyclonal, meaning it recognizes multiple epitopes on the target protein.
Formats: Available in 2 mL or 0.1 mL volumes, with concentrations standardized for experimental use .
Immunogen: A synthetic peptide corresponding to a unique region of the At1g33340 protein sequence (UniProt ID: Q9C502) .
The At1g33340 antibody is employed in various techniques to study protein dynamics:
Specificity: Antibodies targeting poorly characterized proteins risk cross-reactivity with unrelated epitopes. Independent validation (e.g., using Arabidopsis mutants lacking At1g33340) is essential .
Reproducibility: Batch-to-batch variability in polyclonal antibodies may affect experimental consistency .
Functional Studies: Linking antibody-detected protein expression to biological roles requires complementary approaches (e.g., CRISPR knockouts or transcriptomics) .
Functional Annotation: High-throughput phenotyping or interactome studies could clarify the role of the At1g33340 protein.
Antibody Engineering: Developing monoclonal or recombinant versions may improve specificity and reproducibility .
Integration with Omics Data: Correlating antibody-based protein detection with transcriptomic or metabolomic datasets could uncover novel pathways .
The At1g33340 antibody is a polyclonal antibody raised in rabbit against a recombinant Arabidopsis thaliana At1g33340 protein . This antibody specifically targets the protein encoded by the At1g33340 gene in Arabidopsis thaliana (Mouse-ear cress), making it valuable for plant molecular biology research. The antibody has been validated for ELISA and Western blot applications to ensure accurate identification of the target antigen .
For maximum stability and activity retention, the At1g33340 antibody should be stored at -20°C or -80°C upon receipt . It is critical to avoid repeated freeze-thaw cycles as these can compromise antibody integrity and binding efficiency. The antibody is typically supplied in a storage buffer containing 0.03% Proclin 300 as a preservative, along with 50% Glycerol and 0.01M PBS at pH 7.4 . For long-term storage stability, researchers should consider aliquoting the antibody into smaller volumes before freezing to minimize the need for repeated thawing.
According to the product information, the At1g33340 antibody is typically made-to-order with an expected lead time of 14-16 weeks . This extended production timeline is important for researchers to consider when planning experiments, particularly for time-sensitive studies. When designing research schedules, this lead time should be factored into project timelines to avoid experimental delays.
When preparing Arabidopsis samples for At1g33340 detection, researchers should implement plant-specific extraction protocols that preserve protein integrity. Based on standard practices for plant protein extraction, tissues should be flash-frozen in liquid nitrogen and ground to fine powder before extraction with an appropriate buffer containing protease inhibitors. The inclusion of polyvinylpolypyrrolidone (PVPP) is recommended to remove phenolic compounds that may interfere with antibody binding. For membrane-associated proteins, the addition of non-ionic detergents like Triton X-100 may be necessary to solubilize the target protein effectively.
A comprehensive set of controls is crucial for reliable Western blot experiments with At1g33340 antibody. These should include: (1) Positive control using recombinant At1g33340 protein or wild-type Arabidopsis extracts, (2) Negative control using samples from At1g33340 knockout or knockdown plants, (3) Loading control with antibodies against constitutively expressed proteins such as actin or tubulin, (4) Primary antibody omission control to assess secondary antibody specificity, and (5) Peptide competition assay to confirm binding specificity. These controls help distinguish specific signals from artifacts and enable accurate interpretation of experimental results.
Quantitative analysis of Western blot data requires a systematic approach similar to what has been used for other plant proteins in Arabidopsis research . This includes: (1) Using digital image acquisition systems rather than film to ensure a broader linear dynamic range, (2) Running a dilution series to confirm signals fall within the linear detection range, (3) Including appropriate loading controls like actin for normalization, (4) Using densitometry software such as ImageJ for quantification, (5) Normalizing At1g33340 band intensity to loading control intensity, and (6) Analyzing data across multiple biological replicates (minimum n=3) with appropriate statistical tests to ensure reproducibility and reliability of results.
Validating antibody specificity is essential for generating reliable research results. For At1g33340 antibody, validation should include multiple complementary approaches: (1) Western blot analysis comparing wild-type Arabidopsis with At1g33340 knockout mutants to confirm signal absence in knockout plants, (2) Immunoprecipitation followed by mass spectrometry to confirm the identity of the pulled-down protein, and (3) Expression of tagged recombinant At1g33340 protein (with GFP or FLAG tag) to demonstrate co-detection with the antibody. Similar validation approaches have been successfully used with other plant antibodies as demonstrated in research with SUN1,2 antibodies .
The polyclonal nature of the At1g33340 antibody means it contains a heterogeneous mixture of antibodies that recognize different epitopes on the target protein. This characteristic offers both advantages and considerations for experimental design: (1) Enhanced sensitivity through recognition of multiple epitopes, potentially improving detection limits, (2) Greater tolerance to minor protein denaturation or modifications, (3) Possibility of batch-to-batch variability requiring validation of each new lot, and (4) Potential for cross-reactivity with structurally similar proteins. These factors should be considered when designing experiments and interpreting results, particularly when comparing data across different studies or antibody lots.
To distinguish specific signals from background noise, researchers should implement a systematic approach: (1) Optimize antibody concentration through titration experiments to identify the dilution that maximizes signal-to-noise ratio, (2) Implement rigorous blocking protocols using 5% non-fat dry milk or BSA in TBS-T, (3) Include negative controls such as pre-immune serum or secondary antibody-only controls, (4) Perform peptide competition assays where the antibody is pre-incubated with the immunizing peptide, and (5) Compare signals between wild-type and knockout/knockdown plants. This approach is similar to validation strategies reported for other plant antibodies and helps ensure observed signals genuinely represent the target protein.
When encountering weak or inconsistent signals with At1g33340 antibody, researchers should systematically investigate several factors: (1) Protein extraction efficiency—optimize buffer composition and extraction conditions for plant tissues, (2) Protein loading—increase the amount of total protein loaded or consider enrichment techniques, (3) Transfer efficiency—optimize transfer conditions or try wet transfer methods for better protein migration, (4) Blocking conditions—test different blocking agents and times to minimize background without interfering with antibody binding, (5) Antibody concentration—try various dilutions to identify optimal concentration, and (6) Detection sensitivity—employ enhanced chemiluminescence or fluorescent secondary antibodies for improved detection. This systematic approach helps identify and address the specific source of the problem.
Non-specific binding can significantly impact experimental quality. To mitigate this issue: (1) Increase blocking stringency by using higher concentrations of blocking agent or trying alternative blockers like fish gelatin, (2) Add 0.1-0.5% Tween-20 to washing and antibody incubation buffers, (3) Include non-specific competitor proteins such as BSA in antibody dilution buffers, (4) Increase salt concentration in wash buffers to disrupt weak non-specific interactions, (5) Pre-adsorb the antibody with plant extracts from knockout plants, and (6) Optimize incubation times and temperatures. These approaches help enhance signal specificity while reducing background interference.
Discrepancies between transcript and protein levels are common in plant biology research, as demonstrated in studies comparing microarray and protein data . Several factors can contribute to such discrepancies: (1) Post-transcriptional regulation through miRNAs or RNA-binding proteins, (2) Differences in mRNA versus protein stability and turnover rates, (3) Translational efficiency variations under different conditions, (4) Post-translational modifications affecting protein detection, and (5) Technical limitations in detection methods. When investigating At1g33340, researchers should consider these factors and implement parallel analyses of transcript and protein levels across multiple time points to better understand the relationship between transcriptional and translational regulation.
Co-immunoprecipitation (Co-IP) experiments to identify At1g33340 interaction partners require careful optimization: (1) Select extraction conditions that preserve protein-protein interactions by using mild detergents and physiological salt concentrations, (2) Consider crosslinking approaches to stabilize transient interactions, similar to methods used in studies of other plant proteins, (3) Optimize antibody concentration to maximize target capture without creating steric hindrance, (4) Include appropriate negative controls (IgG control, extracts from knockout plants), (5) Validate interactions through reciprocal Co-IP or orthogonal methods, and (6) Combine with mass spectrometry for unbiased interaction partner identification. These approaches can reveal functional networks involving At1g33340 in cellular processes.
For immunolocalization of At1g33340 in plant tissues, researchers should consider: (1) Fixation method—optimize between cross-linking fixatives like paraformaldehyde and precipitating fixatives like methanol based on epitope sensitivity, (2) Antigen retrieval—test methods to expose potentially masked epitopes, (3) Permeabilization—adjust detergent concentration to balance membrane permeability and structural preservation, (4) Blocking parameters—test various blocking agents to minimize non-specific binding, (5) Antibody concentration—perform titration experiments to determine optimal primary and secondary antibody dilutions, and (6) Controls—include negative controls (pre-immune serum, secondary antibody only) and positive controls (known localization patterns of similar proteins). These considerations help ensure specific and reproducible visualization of At1g33340 localization.
To investigate At1g33340 protein dynamics during stress responses, researchers could implement several advanced approaches: (1) Time-course experiments analyzing protein levels across multiple stress time points, similar to transcriptional response studies in Arabidopsis , (2) Subcellular fractionation combined with immunoblotting to track potential translocation between cellular compartments, (3) Immunoprecipitation followed by post-translational modification (PTM) analysis to identify stress-induced modifications, (4) Protein stability assays using translation inhibitors to determine if stress affects protein turnover rates, and (5) Chromatin immunoprecipitation if At1g33340 is suspected to interact with DNA under stress conditions. These approaches provide multi-dimensional insights into protein function during stress adaptation.
Based on established scientific standards , data tables for At1g33340 antibody experiments should follow these principles: (1) Include a clear, descriptive title specific to the experiment (e.g., "Quantification of At1g33340 protein levels in wild-type and stress-treated Arabidopsis seedlings"), (2) Structure tables with the manipulated variable (e.g., treatment conditions) in the left column, raw data from different experimental replicates in the middle columns, and processed data (averages, standard deviations) in the right columns, (3) Ensure all columns have appropriate headers with units and measurement uncertainty indicated, (4) Maintain consistent precision across all measurements with appropriate significant digits, and (5) Present complete data sets with no empty cells . Following this standardized format enhances clarity and facilitates accurate interpretation of research findings.
Integrating protein and transcriptome data provides a more complete understanding of biological processes. When analyzing At1g33340, researchers could: (1) Design experiments collecting matched samples for both RNA and protein analysis under identical conditions, (2) Use appropriate normalization strategies for each data type (reference genes for RNA, loading controls for protein), (3) Calculate correlation coefficients between transcript and protein levels across conditions using Pearson or Spearman methods, (4) Investigate time-course relationships to identify potential delays between transcriptional and translational responses, as demonstrated in microarray validation studies , (5) Apply multivariate analysis methods like principal component analysis to identify patterns in the integrated dataset, and (6) Visualize relationships using scatter plots or heat maps to identify concordant and discordant expression patterns. This multi-level analysis can reveal post-transcriptional regulation mechanisms and functional relationships.